Publications (25) Publications in which a researcher has participated

filter_list Allergy and Immunology

2025

  1. Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML

    Molecular Therapy Oncology, Vol. 33, Núm. 1

2024

  1. Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

    Blood Cancer Journal, Vol. 14, Núm. 1

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

2022

  1. WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing

    Bioinformatics, Vol. 38, Núm. 14, pp. 3645-3647

2021

  1. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

    Blood Cancer Journal, Vol. 11, Núm. 12

2020

  1. Car t-cells in multiple myeloma are ready for prime time

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-16

  2. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  3. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

    Cell, Vol. 181, Núm. 4, pp. 905-913.e7

2019

  1. Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging

    International Journal of Cardiovascular Imaging, Vol. 35, Núm. 4, pp. 675-682

2018

  1. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

    Blood cancer journal, Vol. 8, Núm. 12, pp. 117

2017

  1. Is immunotherapy here to stay in multiple myeloma?

    Haematologica, Vol. 102, Núm. 3, pp. 423-432

2016

  1. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

2013

  1. Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential

    Stem Cells International

2012

  1. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

    BMC Musculoskeletal Disorders, Vol. 13

2011

  1. Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

    Journal of Rheumatology, Vol. 38, Núm. 2, pp. 339-349

2010

  1. Molecular profile and cellular characterization of human bone marrow mesenchymal stem cells: Donor influence on chondrogenesis

    Differentiation, Vol. 80, Núm. 2-3, pp. 155-165

2004

  1. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty

    International Journal of Cardiology, Vol. 95, Núm. SUPPL. 1

2002

  1. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

    Transfusion, Vol. 42, Núm. 9, pp. 1159-1172

2001

  1. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells

    Experimental Hematology, Vol. 29, Núm. 3, pp. 345-355

  2. Ex vivo expansion of umbilical cord blood (UCB) CD34+ cells alters the expression and function of α4β1 and α5β1 integrins

    British Journal of Haematology, Vol. 115, Núm. 1, pp. 213-221